USPTO trademark

ICYTE PRISM

Under examinationUSPTOWord markClass 9Class 35Class 42

"ICYTE PRISM" is a word mark owned by IntegriChain, Inc., filed at the USPTO on July 29, 2026. It is under examination and covers classes 9, 35 and 42.

View IntegriChain, Inc. portfolioGet this data via the API
Official USPTO record
ICYTE PRISM trademark as filed
As filed with the USPTO
Status
Under examination
Since July 29, 2026
Filed
July 29, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50020040
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns ICYTE PRISM

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

IntegriChain, Inc.

Philadelphia, United States

16 trademarks in the portfolioView company

Representative

Matthew Homyk

Blank Rome LLP

Goods and services

What the mark covers

The products and services ICYTE PRISM is filed for, grouped by Nice class.

  • Downloadable computer software using artificial intelligence (AI) for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries; Downloadable computer software for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries

  • Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Providing an on-line database providing business intelligence in the fields of medical devices, pharmaceuticals and life sciences; Business research and data analysis services in the field of pharmaceutical and life sciences commercial data management, market access optimization, drug pricing analysis, and rebate management; Pharmaceutical cost management services and drug utilization review services

  • Software as a service (SAAS) services featuring software using artificial intelligence (AI) for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries; Software as a service (SAAS) services featuring software for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries; Platform as a service (PAAS) featuring computer software platforms for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries; Providing on-line non-downloadable software using artificial intelligence (AI) for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries; Providing on-line non-downloadable software for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. New application office supplied data entered
  2. Application filing receipt mailed
  3. New application entered
FAQ

About ICYTE PRISM

Who owns the trademark "ICYTE PRISM"?

The USPTO trademark "ICYTE PRISM" (application 50020040) is owned by IntegriChain, Inc.

What is the status of "ICYTE PRISM"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ICYTE PRISM and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019fb320-1ad2-76b9-81d5-aa98d775b713
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019fb320-1ad2-76b9-81d5-aa98d775b713",
  "object": "trademark",
  "mark_text": "ICYTE PRISM",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50020040",
  "filing_date": "2026-07-29",
  "nice_classes": [
    9,
    35,
    42
  ],
  "owners": [
    {
      "name": "IntegriChain, Inc.",
      "entity_id": "ent_019eb707-ab1e-751a-b074-234d0efda5bd"
    }
  ]
}